id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-P-0149-0003,FDA,FDA-2004-P-0149,Letter from FDA CDER to Abbott Laboratories,Other,Letter(s),2004-12-06T05:00:00Z,2004,12,2004-11-30T05:00:00Z,,2024-12-23T22:19:43Z,,0,0,090000648046ff09
FDA-2004-P-0149-0004,FDA,FDA-2004-P-0149,Notice of Determination,Notice,N-Notice,2004-11-29T05:00:00Z,2004,11,2004-11-26T05:00:00Z,2004-11-30T04:59:59Z,2024-12-23T22:09:45Z,69FR69373,0,0,090000648046ff0b
FDA-2004-P-0149-0002,FDA,FDA-2004-P-0149,Letter from FDA CDER to Abbott Laboratories,Other,Letter(s),2004-09-20T04:00:00Z,2004,9,2004-09-14T04:00:00Z,,2024-12-23T22:19:26Z,,0,0,090000648046ff08
FDA-2004-P-0149-0001,FDA,FDA-2004-P-0149,Acknowledgment Letter from FDA DMB to Abbott Laboratories,Other,Acknowledgement Letter/Receipt,2004-03-23T05:00:00Z,2004,3,2004-03-23T05:00:00Z,,2024-12-23T21:53:07Z,,0,0,090000648046feff